Car-T Therapy Clinical Trials: Insights on CGT, Thermo Fisher, Miltenyi
T&L Biotechnology Co., Ltd. is at the forefront of innovative cancer treatment with its new CAR-T therapy, designed to harness the power of the body's immune system against malignancies. This breakthrough approach reprograms T cells to target and eliminate cancer cells effectively. Currently, the company is conducting clinical trials to evaluate the safety and efficacy of this cutting-edge therapy across various hematological malignancies
